Metagenics UltraFlora products lead in peer-reviewed clinical data by goal-matched strain (BB536 B. longum, LP299v L. plantarum), while Xymogen ProbioMax products lead with high-CFU practitioner-tier dosing. Metagenics wins on goal-matched clinical evidence; Xymogen wins on practitioner-tier doses. SupplementPractice.com surfaces the citations in patient handouts.
Probiotic Clinical-Data Strength
| Brand | Strain Identity | Goal-Matched Trials |
|---|---|---|
| Metagenics UltraFlora | BB536, LP299v, others | Strong (multiple goals) |
| Xymogen ProbioMax DDS | DDS-1 L. acidophilus | Strong (DDS-1 specific) |
| Best for | Goal-matched intervention | High-CFU loading |
Strain-Specific Trials Beat Generic 'Multi-Strain' Claims
Patients judge probiotics by outcome. Strain-specific trials (BB536 for healthy aging, LP299v for GI comfort) earn the practitioner's confidence and the patient's adherence. SupplementPractice.com surfaces the right strain-trial citation alongside every probiotic recommendation.
